Press "Enter" to skip to content

Europe Sodium-dependent Glucose Cotransporter 2 (SGLT – 2) Market Outlook 2019 | Shows Industry Overview, Size, Share, Remarkable Growth Factors, Types, and Applications Forecast to 2024

Europe

The “Europe Sodium-dependent Glucose Cotransporter 2 (SGLT – 2) Market” 2019 report provides market size (value and volume), market share, growth rate by types, applications, and combines both qualitative and quantitative methods to make micro and macro forecasts in different regions or countries. Europe Sodium-dependent Glucose Cotransporter 2 (SGLT – 2) Market report also aims to provide useful and comprehensive insights into current market trends and future growth scenarios. Europe Sodium-dependent Glucose Cotransporter 2 (SGLT – 2) market report contains information like SWOT analysis, business highlights, strength, weakness, threats and opportunities of industry.

Top Manufacturers of Europe Sodium-dependent Glucose Cotransporter 2 (SGLT – 2) Market Are:

  • Eli Lilly
  • Janssen Pharmaceuticals
  • Boehringer Ingelheim
  • AstraZeneca
  • Bristol Myers Squibb

    Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14245085

    Market Overview:

  • – Jardiance has the highest growth among all the drugs in the SGLT2 class, in terms of revenue, with an expected CAGR of about 22.51%, during the forecast period (2019-2024). Jardiance was reported to have less cardiovascular risk among other oral drugs.
  • – The sodium-dependent glucose cotransporter 2 (SGLT2) market is expected to witness tremendous growth during the forecast period (2019-2024), with a CAGR of 17%, mainly due to the drugs jardiance and farxiga/forxiga.
  • – Jardiance is a once-daily oral medication that is used to control blood glucose levels in people with type 2 diabetes.

    Scope of the Report:

  • The report includes a complete study of SGLT2 inhibitors, which include invokana, jardiance, farxiga, and suglat. The study is further divided into country-wise analysis, which cover all the drugs in the SGLT-2 class.

    Europe Sodium-dependent Glucose Cotransporter 2 (SGLT – 2) Market Report Answers the Following Questions:

    • What will the market size and the growth rate be in 2024?
    • What are the key factors driving the global Europe Sodium-dependent Glucose Cotransporter 2 (SGLT – 2) market?
    • What are the key market trends impacting the growth of the global Europe Sodium-dependent Glucose Cotransporter 2 (SGLT – 2) market?
    • What are the challenges to market growth?
    • Who are the key vendors in the global Europe Sodium-dependent Glucose Cotransporter 2 (SGLT – 2) market?
    • What are the market opportunities and threats faced by the vendors in the global Europe Sodium-dependent Glucose Cotransporter 2 (SGLT – 2) market?
    • Trending factors influencing the market shares of the relevant regions.
    • What are the key outcomes of the five forces analysis of the global Europe Sodium-dependent Glucose Cotransporter 2 (SGLT – 2) market?

    For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/14245085

    Key Market Trends:

    Increasing Side Effects of Invokana

    – Drugs for diabetes are rather expensive for a large segment (middle-class or lower middle-class population) of diabetic patients.
    – While there are only a few moderately priced-generics, like the metformin drugs, other medicines are often more costly and have fewer side effects.
    – One such drug that is losing ground is Johnson & Johnson’s Invokana, due to its increasing side effects.
    – In May, US regulators mandated that the pharmaceutical giant needs to add warnings to Invokana’s label about an increased risk of leg and foot amputations, and in the following month, the company’s cardiovascular outcomes trial, Canvas, confirmed that the medication increased the rate of amputations by about twofold.

    Increasing Diabetic Population

    – As there is an exponential growth of diabetic population YoY, especially type 2 diabetic patients, new innovative drugs are coming up in the market to increase the ease of access to the patients.
    – With the increase in diabetic population, the need and demand for diabetes drugs are expected to increase. The other factors, such as better adoption than other therapies and government initiatives, are driving the diabetes drugs market.

    Market Dynamics: –

    • Drivers: (Developing regions and growing markets)
    • Limitations: (Regional, Key Player facing Issues, Future Barriers for growth)
    • Opportunities: (Regional, Growth Rate, Competitive, Consumption)

    The report provides key statistics on the market status of the Europe Sodium-dependent Glucose Cotransporter 2 (SGLT – 2) Market manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the Europe Sodium-dependent Glucose Cotransporter 2 (SGLT – 2) .

    Purchase this Report (Price 3850 USD for single user license) – https://www.industryresearch.co/purchase/14245085

    Report Objectives:

    • Analyzing the size of the Europe Sodium-dependent Glucose Cotransporter 2 (SGLT – 2) market on the basis of value and volume.
    • Accurately calculating the market segments, consumption, and other dynamic factors of different sections of the global Europe Sodium-dependent Glucose Cotransporter 2 (SGLT – 2) market.
    • Determining the key dynamics of the Europe Sodium-dependent Glucose Cotransporter 2 (SGLT – 2) market.
    • Highlighting significant trends of the Europe Sodium-dependent Glucose Cotransporter 2 (SGLT – 2) market in terms of manufacture, revenue, and sales.
    • Deeply summarizing top players of the Europe Sodium-dependent Glucose Cotransporter 2 (SGLT – 2) market and showing how they compete in the industry.
    • Studying industry processes and costs, product pricing, and various trends related to them.
    • Displaying the performance of different regions and countries in the global Europe Sodium-dependent Glucose Cotransporter 2 (SGLT – 2) market.

    Detailed TOC of Europe Sodium-dependent Glucose Cotransporter 2 (SGLT – 2) Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Drivers
    4.3 Restraints
    4.4 Porter’s Five Forces Analysis
    4.4.1 Bargaining Power of Suppliers
    4.4.2 Bargaining Power of Consumers
    4.4.3 Threat of New Entrants
    4.4.4 Threat of Substitute Products and Services
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 By Drug
    5.1.1 Sodium-dependent Glucose Cotransport 2 (SGLT-2) Inhibitor (Value and Volume, 2012-2024)
    5.1.1.1 Invokana (Canagliflozin)
    5.1.1.2 Jardiance (Empagliflozin)
    5.1.1.3 Farxiga/Forxiga (Dapagliflozin)
    5.1.1.4 Suglat (Ipragliflozin)
    5.2 By Geography
    5.2.1 Europe
    5.2.1.1 France (Value and Volume, 2012-2024)
    5.2.1.1.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.1.2 Germany (Value and Volume, 2012-2024)
    5.2.1.2.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.1.3 Italy (Value and Volume, 2012-2024)
    5.2.1.3.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.1.4 Spain (Value and Volume, 2012-2024)
    5.2.1.4.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.1.5 United Kingdom (Value and Volume, 2012-2024)
    5.2.1.5.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.1.6 Russia (Value and Volume, 2012-2024)
    5.2.1.6.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.1.7 Rest of Europe (Value and Volume, 2012-2024)
    5.2.1.7.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)

    6 MARKET INDICATORS
    6.1 Type-1 Diabetes Population (2012-2024)
    6.2 Type-2 Diabetes Population (2012-2024)

    7 COMPETITIVE LANDSCAPE
    7.1 COMPANY PROFILES
    7.1.1 Eli Lilly
    7.1.2 Janssen Pharmaceuticals
    7.1.3 Boehringer Ingelheim
    7.1.4 AstraZeneca
    7.1.5 Bristol Myers Squibb
    7.2 MARKET SHARE ANALYSIS
    7.2.1 Eli Lilly
    7.2.2 Janssen Pharmaceuticals
    7.2.3 Boehringer Ingelheim
    7.2.4 AstraZeneca

    8 MARKET OPPORTUNITES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    FRP Grating Market 2019 Insight by Development, Product Demand, Latest Technology, Upcoming Trends, and Growth Rate Forecast to 2023

    Sodium Aluminate Market 2019 Industry Size, Trends, Global Growth, Insights and Forecast Research Report 2024

    Estimated Market Size and Share of Lithium Hydroxide Market 2019 –Market Size, Share, CAGR%, Production, Consumption, Key Players, Future Demand, and Forecast till 2024

    Memory Bank Market 2019 Global Industry Leading Players Update, Gross Margin Analysis, Size, Development History, Business Prospect and Industry Research Report 2025

  • Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *